Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
life sciences
boston
boston top stories
gene therapy
national blog main
national top stories
new york blog main
san diego blog main
san francisco blog main
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
bill &
bioinnovation capital
biolabs
bluebird bio
boulder/denver blog main
boulder/denver top stories
chemotherapy
clinical trials
daraprim
democrats
detroit blog main
detroit top stories
donald
drug price
drug pricing
drugs
duchenne muscular dystrophy
dyne therapeutics
epipen
epipens
exome
facioscapulohumeral muscular dystrophy
federal
fee
fine
What
drug
3
×
long
3
×
ago
anathema
awaited
biotech
biotechs
considering
data
democrat
details
diseases
driving
dyne
early
elements
expected
experimental
eyes
genetic
good
having
healthcare
history
house
humans
improved
industry
innovation
innovations
investment
ipo
ipos
leaked
life
look
lower
medical
medicines
monday
Language
unset
3
×
Current search:
drug
×
unset
×
biotech
×
long
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly